April 13, 2017 Columns by Cathy Chester Why Staying Informed About Multiple Sclerosis is Important A lot has changed in multiple sclerosis research and treatment since I was diagnosedĀ 30 years ago. Here are a few things I was told originally that are no longer true: Thereās less than a 1% chance for a child to inherit their motherās…
April 10, 2017 News by Charles Moore Bike MS Event in Fort Worth Expected to Attract 2,000 Cyclists and Raise $1.8M for MS Research More than 2,000 bicyclists are expected to joinĀ in the 30th Annual Running of the Bike MS: Sam’s Club Round-Up Ride, set for May 6-7 in Fort Worth, Texas.Ā The two-day, 163-mile trek’s objective is to raise $1.8 millionĀ in funding forĀ people living with multiple sclerosis (MS). Last year, participants pedaled 279,000 miles…
April 5, 2017 News by Joana Fernandes, PhD UCSF Neurologist Played Key Role in MS Research Turning to B-Cells, Essential Step to Ocrevus Dr. Stephen Hauser, chair of the neurology department at the University of California San Francisco, was instrumental in the early research and laterĀ clinical trials that ultimately led toĀ Ocrevus (ocrelizumab), the first therapyĀ approved by the U.S. Food and Drug Administration (FDA)Ā for bothĀ relapsing MSĀ (RMS) and primary progressive multiple sclerosis…
January 26, 2017 Columns by Laura Kolaczkowski Join Me and Advocate for MS One of my sisters called to let me know that CNN was doing live coverage of the Womenās March that was taking place in all 50 U.S. states, as well as many other countries. While we talked, one of the speakers came on and observed that the issues facing…
January 9, 2017 News by Patricia Silva, PhD EU Awards $15M to Global Consortium Aiming for Personal MS Treatments The European Commission isĀ awardingĀ 15 million euros to support MultipleMS, a large global projectĀ designed to develop newĀ personalized medicine approaches for multiple sclerosis (MS) patients. The funds, equal toĀ about $15.2 million, will be provided through the agency’s Horizon2020 Framework Programme for Research and Innovation. The program, the European Union’s largest research…
December 22, 2016 Columns by Laura Kolaczkowski We Need Pharma If We Hope to Find a Cure for MS We all know the credit card commercial with actor Samuel L. Jackson talking about the buying power and the return on a certain credit card. He speaks about the bonus cash-back offers you can accrue if you just keep spending money and putting it on your credit card.Ā The tag…
December 22, 2016 News by Alexandra Andersson, PhD Cures Act May Speed Approval of Stem Cell Therapies for MS and Other Diseases The 21st Century Cures Act, recently signed into law by President Barack Obama, includes provisions that aim to speed up the process by whichĀ the U.S. Food and Drug Administration (FDA) reviewsĀ stem cell treatments for patients with degenerative diseases, such as multiple sclerosis, rheumatoid arthritis, and Parkinson’s disease. This act also…
September 23, 2016 News by Joana Fernandes, PhD Progressive MS Alliance Awards $18M to 3 Research Projects into Disease Treatments, Expanded Testing The International Progressive Multiple Sclerosis (MS) Alliance, a worldwide group of MS organizations that supportĀ research efforts, has awarded three, four-year grants ā called Collaborative Network Awards, and worth $6 million each ā to speed work intoĀ potential treatments for progressive MS. Found in about 15 percent of all initially diagnosed…
September 14, 2016 News by Patricia Silva, PhD #ECTRIMS2016 – MS Care and Research Lagging in Middle East, Experts Say Multiple sclerosis (MS) care and research is lagging behind in the Middle East compared to countries in Europe and North America, according to research presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2016 CongressĀ taking placeĀ in London through Sept. 17. Two presentations inĀ a session titled “…
August 25, 2016 News by Charles Moore Patient-led Study, REAL MS, Invites Adults to Help Advance and Direct MS Research An innovation in multiple sclerosis (MS) research has been launched byĀ the iConquerMSĀ initiative ā a longitudinal, prospective study called “REAL MS,” an acronym for “Research Engagement About Life with Multiple Sclerosis,” with aĀ goal of accelerating research into personalized treatments for MS patients. This type of study collects repeat…
August 18, 2016 News by Patricia Silva, PhD Specific Definition of Fatigue in MS Proposed as Way to Advance Research into Symptom Researchers from Colorado State University propose a new model of fatigue in multiple sclerosis (MS), designed to overcome the lack of a unified definition of fatigue that can be objectively tested using experimental approaches. With this model, the authors behind the article,Ā “Fatigue in Multiple Sclerosis: Misconceptions…
June 23, 2016 Columns by admin MS is Linked to Glandular Fever, I Have No Doubt In my mind, MS is linked to glandular fever. From personal experience, there is no room for doubt of any kind. Trouble is, though, that my experience and belief is not proof. And that is why I find that efforts to establish a definite link between glandular fever, often known…
May 30, 2016 News by Charles Moore #CMSC16 — Multiple Sclerosis News Today to Provide Extensive On-Site Coverage of Annual Meeting Multiple Sclerosis News Today will provide extended on-site coverage of the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual MeetingĀ June 1-4 at the Gaylord National Resort and Convention Center in National Harbor, Maryland, across the harbor from the nation’s capital. Our news team will be posting feature articles on presentations…
March 2, 2016 News by Margarida Azevedo, MSc Therapeutic Target for Stabilizing Histamine, an Inflammatory Agent in MS, Identified in Fruit Fly Study Researchers at the University of Massachusetts Medical School, workingĀ in the fruit fly model,Ā identified an organic cation transporter, CarT (carcinine transporter), that is crucial to the recycling of histamine in the brain and the maintenance of healthy vision. Histamine is a neurotransmitter involved in chronic inflammation and pathogenesis in multiple…
February 25, 2016 News by Patricia Silva, PhD Peripheral Neuropathy Reversed in Zebrafish After Treatment with 2 Drugs A researcher hasĀ identified two drugs that may be used to reverse peripheral nerve damage, also referred to as peripheral neuropathy, resulting from diseases like multiple sclerosis (MS) and diabetes, the use of chemotherapy in the treatment of some cancers, or traumatic injuries. The researcher,Ā Sandra Rieger, PhD, is an assistant professor…
February 18, 2016 News by Patricia Silva, PhD US Moves Step Closer to National MS, Neurological Disease Registry with Senate Panel Vote The U.S. Senate health committee recently passed the āAdvancing Research for Neurological Diseases Act of 2015ā (S. 849), sponsored by Sens.Ā Johnny IsaksonĀ and Chris Murphy, whichĀ wouldĀ create a nationwide system to track the incidence and prevalence of neurological diseases, including multiple sclerosis (MS), and thatĀ one day might help lead to a…
October 5, 2015 News by Charles Moore Multiple Sclerosis News Today To Provide Live, On-Site Coverage Of 31st Annual #ECTRIMS2015 Congress The 31st meeting of the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (#ECTRIMS2015) is being held this week from October 7 to 10 inĀ Barcelona, Spain. The conference was last held in the Catalonian capital in 1992. Multiple Sclerosis News Today…
June 22, 2015 News by Patricia Silva, PhD Animal Models Offer New Insights Into Energy Metabolism in Multiple Sclerosis Researchers atĀ United Arab Emirates University in Abu Dhabi have recently published in the journal BMC Neuroscience new insights into the involvement of mitochondria and energy metabolism in the pathology of multiple sclerosis (MS) in rats. The study is entitled āBioenergetics of the spinal…
June 3, 2015 News by admin Approach to Treating MS May be Transformed Thanks to Newly Discovered Connection Between Immune-Nervous Systems An exciting new discovery has turned the medical world upside down, and could have important implications for the treatment of multiple sclerosis (MS). It turns out that previously undiscovered vessels exist that connect the nervous system and immune system directly. The study, titled “Structural and functional features…
December 11, 2014 News by Isaura Santos MS Society Heralds 2014 as a Year Of Great Progress in Multiple Sclerosis Research 2014 was a year of major progress in research for treating and curingĀ multiple sclerosis (MS), according to the National Multiple Sclerosis Society. This year theĀ National Multiple Sclerosis Society reports that the organizationĀ invested over $50 million into 380 new and ongoing researchĀ initiatives and projects for MS. The SocietyĀ remains highly…